- Home
- IPSC vs DIBS Comparison
IPSC vs DIBS Comparison
Compare IPSC & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPSC | DIBS |
|---|---|---|
| Founded | 2019 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.7M | 201.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IPSC | DIBS |
|---|---|---|
| Price | $2.33 | $4.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $3.50 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 976.3K | 201.4K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.07 | 14.04 |
| EPS | ★ 0.11 | N/A |
| Revenue | $6,589,000.00 | ★ $88,257,000.00 |
| Revenue This Year | $1,590.09 | $3.73 |
| Revenue Next Year | N/A | $2.21 |
| P/E Ratio | $20.64 | ★ N/A |
| Revenue Growth | ★ 194.81 | 4.22 |
| 52 Week Low | $0.34 | $2.30 |
| 52 Week High | $2.71 | $6.62 |
Technical Indicators
Market Signals| Indicator | IPSC | DIBS |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 36.15 |
| Support Level | $0.49 | $2.54 |
| Resistance Level | $2.71 | $6.25 |
| Average True Range (ATR) | 0.19 | 0.29 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 79.33 | 40.36 |
Price Performance
Historical ComparisonAbout IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.